26.07.2007 13:00:00
|
Millennium Cell and The Dow Chemical Company Achieve Milestone 2
Millennium Cell Inc. (NASDAQ: MCEL), a leading developer of hydrogen
battery technology, today announced that Milestone 2 of the joint
development program with The Dow Chemical Company ("Dow”)
has been achieved. This milestone was accomplished through the delivery
to the U.S. Air Force of Protonex Technology Corporation’s
ProCore™ C50 and C720 fuel cell power products
which utilize Millennium Cell’s Hydrogen on
Demand® technology.
These 50-watt power systems are currently being tested at the U.S.
Department of Defense Fuel Cell Test and Evaluation Center which is
operated by Concurrent Technologies Corporation in Johnstown, PA.
"An important focus of this three-year joint
development program with Dow was to move Millennium Cell’s
Hydrogen on Demand® liquid fuel technology
from the lab into commercially viable products,"
commented H. David Ramm, Millennium Cell’s
Chief Executive Officer. "The achievement of
the second milestone marks an important step in the maturation of our
hydrogen storage technology which we will continue to advance towards
commercialization. Additionally, through this collaboration with Dow, we
have identified a new hydrogen fuel technology that is especially
well-suited for the consumer electronics market. As a result, we will
focus our third and final milestone of this joint development agreement
on the advancement of this new technology, Solid State HOD™.”
Millennium Cell and Dow have been collaborating on an innovative
hydrogen storage technology (Solid State HOD™)
which has unlimited shelf life, no moving parts, and can significantly
extend the runtime of fuel cell powered consumer electronics devices.
Based on the results to date, the companies have modified their joint
development program in which the final milestone (Milestone 3) will
focus exclusively on Solid State HOD™ for
consumer electronics applications. Further details about the milestone
change and other program modifications are included in Millennium Cell’s
Current Report on Form 8-K which is being filed today with the
Securities and Exchange Commission.
Milestone 3 calls for the development of a pre-production hydrogen
storage cartridge capable of addressing energy storage needs for a
portable consumer application for a large volume market such as mobile
phone handsets, chargers, 2-way radios and laptop computers.
Simultaneous with the development of this cartridge, Millennium Cell
will focus on securing a commercialization partner, such as a major
consumer electronics original equipment manufacturer (OEM), capable of
designing this new technology into products. Securing this
commercialization partner would mark a successful end to the joint
development program between the two parties.
"We are very excited about the results and
pace of progress on our Solid State HOD™
technology since its conception approximately two years ago. Dow’s
expertise in materials, chemistry, and thermodynamics has been
instrumental in the development of this exciting technological
advancement,” concluded Mr. Ramm.
"Millennium Cell’s
Solid State HOD™ technology has the potential
to exceed current and forecasted battery performance. Consumer
electronics markets can benefit from a better power source and we
believe that fuel cells can play a significant role in the future of
portable power. Dow is pleased to continue our relationship with
Millennium Cell and we look forward to delivering a proven technology to
a commercialization partner at the end of the joint development program
in 2008," said James H. Plonka, Dow Vice President, Corporate Venture
Capital.
Background information on the Millennium Cell and Dow transaction
In April 2005, Millennium Cell and Dow entered into a three-year,
milestone-driven joint development program to collaborate on the
development and commercialization of portable fuel cell systems for use
in consumer electronics and military applications. These hydrogen
batteries are based on Millennium Cell’s
patented Hydrogen on Demand® technology and
proton exchange membrane fuel cells to convert hydrogen and oxygen to
electricity. Since the program’s inception,
Dow has been providing a combination of business and technical resources
to aid in the achievement of these milestones.
After the milestone is achieved, Millennium Cell is obligated to issue
shares of its Series A2 Preferred Stock that were earned by Dow through
human resource and intellectual property contributions toward
achievement of the second milestone within 70 days. The number of Series
A Preferred shares to be issued will be determined in accordance with
the joint development agreement. Dow has expressed its intent to
maintain an investment in Millennium Cell but may periodically liquidate
some or all of the shares it acquires through the joint development
program.
The Current Report on Form 8-K filed today by Millennium Cell provides
additional information with respect to the anticipated issuance of
Series A-2 Preferred Stock in consideration for the second milestone
achievement as well as further information on the modifications to the
joint development program as indicated above.
About Millennium Cell
Millennium Cell is a leader in the development of hydrogen battery
technology used to power portable applications. Through its proprietary
Hydrogen on Demand®
fuel cartridges and PowerSkin™ fuel cell
modules, the Company provides increased energy density resulting in
longer runtime and lighter weight in a compact space. The Company is
working with market partners to meet the demand for a better battery in
the military, medical, industrial and consumer electronics markets. For
more information, visit www.millenniumcell.com.
About The Dow Chemical Company
Dow is a diversified chemical company that harnesses the power of
science and technology to improve living daily. The Company offers a
broad range of innovative products and services to customers in more
than 175 countries, helping them to provide everything from fresh water,
food and pharmaceuticals to paints, packaging and personal care
products. Built on a commitment to its principles of sustainability, Dow
has annual sales of $49 billion and employs 43,000 people worldwide.
References to "Dow" mean The Dow Chemical Company and its consolidated
subsidiaries unless otherwise expressly noted. For further information,
visit Dow’s web site at www.dow.com.
Cautionary Note Regarding
Forward-looking Statements from Millennium Cell: This press release may include statements that are not historical
facts and are considered ``forward-looking”
within the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements reflect Millennium Cell’s
current views about future events and financial performance and are
subject to risks. Forward-looking statements are identified by
their use of terms and phrases such as "believe,” "expect,” "plan,” "anticipate,” "on
target” and similar expressions identifying
forward-looking statements. Investors should not rely on
forward-looking statements because they are subject to a variety of
risks, uncertainties and other factors, many of which are outside of our
control, that could cause actual results to differ materially from
Millennium Cell’s expectations, and
Millennium Cell expressly does not undertake any duty to update
forward-looking statements. These factors include, but are not
limited to, the following: (i) the cost and timing of development and
market acceptance of Millennium Cell’s
hydrogen fuel storage and delivery system; (ii) the cost and commercial
availability of the quantities of raw materials required by the hydrogen
fuel storage and delivery systems; (iii) competition from current,
improving and alternative power technologies; (iv) Millennium Cell’s
ability to raise capital at the times, in the amounts and at the costs
and terms that are acceptable to fund the development and
commercialization of its hydrogen fuel storage and delivery system and
its business plan; (v) Millennium Cell’s
ability to protect its intellectual property; (vi) Millennium Cell’s
ability to achieve budgeted revenue and expense amounts; (vii)
Millennium Cell’s ability to generate
revenues from the sale or license of, or provision of services related
to, its technology; (viii) Millennium Cell’s
ability to form strategic alliances or partnerships to help promote our
technology and achieve market acceptance; (ix) Millennium Cell’s
ability to generate design, engineering or management services revenue
opportunities in the hydrogen generation or fuel cell markets; (x)
Millennium Cell’s ability to secure
government funding of its research and development and technology
demonstration projects; and (xi) other factors discussed under the
caption "Risk Factors”
in Millennium Cell’s Annual Report on Form
10-K for the year ended December 31, 2006. Cautionary Note Regarding
Forward-looking Statements from The Dow Chemical Company:
The forward-looking statements contained in this document involve risks
and uncertainties that may affect The Dow Chemical Company’s
operations, markets, products, services, prices and other factors as
discussed in filings with the Securities and Exchange Commission. These
risks and uncertainties include, but are not limited to, economic,
competitive, legal, governmental and technological factors. Accordingly,
there is no assurance that Dow’s expectations
will be realized. Dow assumes no obligation to provide revisions to any
forward-looking statements should circumstances change, except as
otherwise required by securities and other applicable laws.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Millennium Cell Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Millennium Cell Inc.mehr Analysen
Aktien in diesem Artikel
Millennium Cell Inc. | 0,00 | 0,00% |
Indizes in diesem Artikel
NASDAQ Comp. | 19 756,78 | 0,64% |